初诊PET/CT改变头颈部鳞状细胞癌患者的治疗意图
这项前瞻性盲法配对队列研究纳入307例组织学确诊的原发性头颈部鳞状细胞癌患者,比较基于PET/CT与基于胸部X线+头颈部MRI的影像策略对多学科团队会议治疗意图决策的影响。基于PET/CT时91%推荐根治性治疗、9%推荐姑息性治疗,基于CXR/MRI时99%推荐根治性、1%推荐姑息性,绝对差异8%具有统计学显著性(95%CI 4.8%-11.5%,p<0.001)。
要点
- 307例初诊头颈部鳞癌患者,比较PET/CT与胸部X线+头颈部MRI两种影像策略下的多学科治疗意图决策。
- 基于CXR/MRI时303例(99%)推荐根治性治疗、4例(1%)推荐姑息性治疗。
- 基于PET/CT时278例(91%)推荐根治性治疗、29例(9%)推荐姑息性治疗,绝对差异8%(95%CI 4.8%-11.5%,p<0.001)。
核心结论
- 与胸部X线+头颈部MRI的标准影像策略相比,基于PET/CT的影像策略显著改变了多学科团队会议对头颈部鳞状细胞癌患者治疗意图的决策。
研究设计与样本
- 前瞻性盲法配对队列研究,连续纳入组织学证实的原发性头颈部鳞状细胞癌患者,所有患者诊断性活检前均接受胸部X线+头颈部MRI和PET/CT检查。
- 按标准实践以全部可用影像召开常规多学科团队会议;至少3个月后召开第一次项目多学科团队会议,仅基于CXR/MRI或PET/CT之一得出结论;再间隔3个月后以另一互补影像模态召开第二次项目多学科团队会议。
- 共纳入307例患者。
主要发现
- 基于CXR/MRI,303例(99%)被推荐根治性治疗,仅4例(1%)被推荐姑息性治疗。
- 基于PET/CT,多学科团队会议判定278例(91%)适合根治性治疗,29例(9%)适合姑息性治疗。
- 两种影像策略间绝对差异为8%,具有统计学显著性(95%CI 4.8%-11.5%,p<0.001)。
关键数值与推荐
- 基于CXR/MRI:根治性治疗303/307例(99%),姑息性治疗4/307例(1%)。
- 基于PET/CT:根治性治疗278/307例(91%),姑息性治疗29/307例(9%)。
- 绝对差异8%(95%CI 4.8%-11.5%,p<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: In patients with newly diagnosed head and neck squamous cell carcinoma (HNSCC), we wanted to examine the differences in overall treatment decisions, i.e. curative versus palliative treatment intent, reached by a multidisciplinary team conference (MDTC) based on 18F-fluoro-deoxy-glucose-positron emission tomography/computed tomography (PET/CT) or chest X-ray + MRI of the head and neck (CXR/MRI). PATIENTS AND METHODS: This was a prospective blinded cohort study based on paired data. Consecutive patients with histologically verified primary HNSCC were invited to participate. All included patients underwent CXR/MRI and PET/CT before diagnostic biopsy. An ordinary MDTC using all available imaging was conducted as per standard practice. After at least 3 months (to eliminate recall bias in the team), the first project MDTC was conducted, based on either CXR/MRI or PET/CT, and the tumor board drew conclusions regarding treatment. After an additional 3 months, a second project MDTC was conducted using the complementary imaging modality. RESULTS: A total of 307 patients were included. Based on CXR/MRI, 303 patients (99%) were recommended for curative treatment and only four patients (1%) for palliative treatment. Based on PET/CT, the MDTC concluded that 278 (91%) patients were suitable for curative treatment and 29 (9%) patients for palliative treatment. The absolute difference of 8% was statistically significant (95% CI: 4.8%-11.5%, p < 0.001). CONCLUSIONS: A PET/CT-based imaging strategy significantly changed the decisions regarding treatment intent made by a MDTC for patients diagnosed with HNSCC, when compared with the standard imaging strategy of CXR/MRI.
引用
- Rohde M, Nielsen AL, Johansen J, et al. Up-front PET/CT changes treatment intent in patients with head and neck squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 2017. PMID: 29124279. doi:10.1007/s00259-017-3873-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。